These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17151556)

  • 1. [Proteomics of breast cancer: From differential to functional analysis].
    Hondermarck H
    J Soc Biol; 2006; 200(2):199-202. PubMed ID: 17151556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proteomics and breast cancer: new perspectives and limitations].
    Hondermarck H
    Pathol Biol (Paris); 2006 May; 54(4):194-8. PubMed ID: 16632259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional proteomics in oncology: to understand more than to describe].
    Com E; Hondermarck H
    Med Sci (Paris); 2007 Mar; 23 Spec No 1():27-30. PubMed ID: 17669350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer: when proteomics challenges biological complexity.
    Hondermarck H
    Mol Cell Proteomics; 2003 May; 2(5):281-91. PubMed ID: 12775769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomolecular features of clinical relevance in breast cancer.
    Daidone MG; Paradiso A; Gion M; Harbeck N; Sweep F; Schmitt M
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S3-14. PubMed ID: 15095022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LinkedOmics: analyzing multi-omics data within and across 32 cancer types.
    Vasaikar SV; Straub P; Wang J; Zhang B
    Nucleic Acids Res; 2018 Jan; 46(D1):D956-D963. PubMed ID: 29136207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model.
    Kreunin P; Yoo C; Urquidi V; Lubman DM; Goodison S
    Proteomics; 2007 Jan; 7(2):299-312. PubMed ID: 17205601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Analysis of Stage-II Breast Cancer from Formalin-Fixed Paraffin-Embedded Tissues.
    Abdullah Al-Dhabi N; Srigopalram S; Ilavenil S; Kim YO; Agastian P; Baaru R; Balamurugan K; Choi KC; Valan Arasu M
    Biomed Res Int; 2016; 2016():3071013. PubMed ID: 27110560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ELF magnetic fields on protein expression profile of human breast cancer cell MCF7.
    Li H; Zeng Q; Weng Y; Lu D; Jiang H; Xu Z
    Sci China C Life Sci; 2005 Oct; 48(5):506-14. PubMed ID: 16315602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas.
    Olsen L; Campos B; Winther O; Sgroi DC; Karger BL; Brusic V
    BMC Med Genomics; 2014; 7 Suppl 3(Suppl 3):S2. PubMed ID: 25521819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth signaling in breast cancer cells: outcomes and promises of proteomics.
    Adriaenssens E; Lemoine J; El Yazidi-Belkoura I; Hondermarck H
    Biochem Pharmacol; 2002 Sep; 64(5-6):797-803. PubMed ID: 12213572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific changes in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation.
    Crugliano T; Quaresima B; Gaspari M; Faniello MC; Romeo F; Baudi F; Cuda G; Costanzo F; Venuta S
    Int J Biochem Cell Biol; 2007; 39(1):220-6. PubMed ID: 17005433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel clusters of highly expressed genes accompany genomic amplification in breast cancers.
    Ito E; Honma R; Yanagisawa Y; Imai J; Azuma S; Oyama T; Ohwada S; Akiyama T; Nomura N; Inoue J; Watanabe S; Semba K
    FEBS Lett; 2007 Aug; 581(21):3909-14. PubMed ID: 17662721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis.
    Jhan JR; Andrechek ER
    Oncogene; 2017 Jun; 36(25):3553-3561. PubMed ID: 28135251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics using mammospheres as a model system to identify proteins deregulated in breast cancer stem cells.
    Li G; Zhao F; Cui Y
    Curr Mol Med; 2013 Mar; 13(3):459-63. PubMed ID: 23331018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of C35 in breast carcinomas is associated with tumor progression and lymphnode metastasis.
    Yin K; Ba Z; Li C; Xu C; Zhao G; Zhu S; Yan G
    Biosci Trends; 2015 Dec; 9(6):386-92. PubMed ID: 26781796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research.
    Celis JE; Gromov P; Gromova I; Moreira JM; Cabezón T; Ambartsumian N; Grigorian M; Lukanidin E; Thor Straten P; Guldberg P; Bartkova J; Bartek J; Lukas J; Lukas C; Lykkesfeldt A; Jäättelä M; Roepstorff P; Bolund L; Ørntoft T; Brünner N; Overgaard J; Sandelin K; Blichert-Toft M; Mouridsen H; Rank FE
    Mol Cell Proteomics; 2003 Jun; 2(6):369-77. PubMed ID: 12832461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative proteome analysis of breast cancer and normal breast.
    Luo Y; Zhang J; Liu Y; Shaw AC; Wang X; Wu S; Zeng X; Chen J; Gao Y; Zheng D
    Mol Biotechnol; 2005 Mar; 29(3):233-44. PubMed ID: 15767701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.
    Hodgkinson VC; Eagle GL; Drew PJ; Lind MJ; Cawkwell L
    Cancer Lett; 2010 Aug; 294(1):13-24. PubMed ID: 20176436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer network activity associated with therapeutic response and synergism.
    Serra-Musach J; Mateo F; Capdevila-Busquets E; de Garibay GR; Zhang X; Guha R; Thomas CJ; Grueso J; Villanueva A; Jaeger S; Heyn H; Vizoso M; Pérez H; Cordero A; Gonzalez-Suarez E; Esteller M; Moreno-Bueno G; Tjärnberg A; Lázaro C; Serra V; Arribas J; Benson M; Gustafsson M; Ferrer M; Aloy P; Pujana MÀ
    Genome Med; 2016 Aug; 8(1):88. PubMed ID: 27553366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.